Hepcidin mutation in a β-thalassemia major patient with persistent severe iron overload despite chelation therapy

Lorena Duca; Paola Delbini; Isabella Nava; Maria Domenica Cappellini; Anna Meo

首页> 外文期刊>Internal and Emergency Medicine >Hepcidin mutation in a β-thalassemia major patient with persistent severe iron overload despite chelation therapy

【24h】

Hepcidin mutation in a β-thalassemia major patient with persistent severe iron overload despite chelation therapy

机译：尽管使用螯合疗法但仍持续存在严重铁超负荷的重型β地中海贫血患者中的铁调素突变

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Internal and Emergency Medicine》 |2010年第1期|83-85|共3页
作者
Lorena Duca; Paola Delbini; Isabella Nava; Maria Domenica Cappellini; Anna Meo;
展开▼
作者单位

Department of Internal Medicine, Maggiore Policlinico, Mangiagalli and Regina Elena Foundation IRCCS, University of Milan, Milan, Italy;

Department of Internal Medicine, Maggiore Policlinico, Mangiagalli and Regina Elena Foundation IRCCS, University of Milan, Milan, Italy;

Department of Internal Medicine, Maggiore Policlinico, Mangiagalli and Regina Elena Foundation IRCCS, University of Milan, Milan, Italy;

Department of Internal Medicine, Maggiore Policlinico, Mangiagalli and Regina Elena Foundation IRCCS, University of Milan, Milan, Italy;

Department of Pediatrics “G.Martino” Policlinico, Faculty of Medicine, University of Messina, Via Consolare Valeria, Messina, Italy;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. A new era in iron chelation therapy: the design of optimal, individually adjusted iron chelation therapies for the complete removal of iron overload in thalassemia and other chronically transfused patients. [J] . Hemoglobin: International Journal for Hemoglobin Research . 2009,第5期

机译：铁螯合疗法的新纪元：设计最佳的，可单独调整的铁螯合疗法，以完全消除地中海贫血和其他长期输血患者的铁超负荷。
2. Successful chelation therapy with the combination of deferasirox and deferiprone in a patient with thalassaemia major and persisting severe iron overload after single-agent chelation therapies. [J] . Voskaridou E, Christoulas D, Terpos E British Journal of Haematology . 2011,第5期

机译：单药螯合治疗后严重地中海贫血患者的铁结合成功使用地拉罗司和去铁酮进行螯合治疗。
3. Successful chelation therapy with the combination of deferasirox and deferiprone in a patient with thalassaemia major and persisting severe iron overload after single-agent chelation therapies [J] . Ersi Voskaridou, Dimitrios Christoulas, Evangelos Terpos British Journal of Haematology . 2011,第5期

机译：单药螯合治疗后重度地中海贫血并持续严重铁超负荷的患者成功应用地拉罗司和去铁酮联合螯合治疗
4. Effects of iron overload on cellular immunity in patients with beta thalassemia major [C] . Erdem-Curuca, S., Atasever, Workshop on Macro, Trace and Ultratrace Elements; 20040924-25; Jena(DE) . 2004

机译：铁超负荷对重型β地中海贫血患者细胞免疫的影响
5. Development of nanotechnologies for cancer and iron chelation therapy [D] . Wang, Yan. 2015

机译：癌症和铁螯合疗法的纳米技术开发
6. Efficacy and safety of combined oral iron chelation therapy with deferasirox and deferiprone in a patient with beta-thalassemia major and persistent iron overload [O] . Samin Alavi, Elham Sadeghi, Azin Ashenagar 2014

机译：β地中海贫血严重和持续性铁超负荷患者联合口服铁螯合疗法与地拉罗司和去铁酮的疗效和安全性
7. Efficacy and safety of combined oral iron chelation therapy with deferasirox and deferiprone in a patient with beta-thalassemia major and persistent iron overload [O] . Samin Alavi, Elham Sadeghi, Azin Ashenagar 2014

机译：用β-地中海贫血症主要和持久性铁超负荷患者脱硫和脱铁毒剂和脱铁酮和脱普隆的疗效和安全性

Hepcidin mutation in a β-thalassemia major patient with persistent severe iron overload despite chelation therapy

著录项

引文网络

相似文献

相关主题

期刊订阅